IP Verse

Prediction Of Outcome In Patients With Chronic Obstructive Pulmonary Disease - EP2823314

The patent EP2823314 was granted to Brahms on Apr 12, 2017. The application was originally filed on Feb 26, 2013 under application number EP13707113A. The patent is currently recorded with a legal status of "Revoked".

EP2823314

BRAHMS
Application Number
EP13707113A
Filing Date
Feb 26, 2013
Status
Revoked
Dec 19, 2023
Publication Date
Apr 12, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

RADIOMETER MEDICAL APSJan 12, 2018MAIWALDADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP20090011073
INTERNATIONAL-SEARCH-REPORTDE102007021443
INTERNATIONAL-SEARCH-REPORTUS2004121343
INTERNATIONAL-SEARCH-REPORTUS2010332141
INTERNATIONAL-SEARCH-REPORTWO2007131031
INTERNATIONAL-SEARCH-REPORTWO2008077958
INTERNATIONAL-SEARCH-REPORTWO2009129454
OPPOSITIONWO2013131621

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- BERNASCONI M. et al., "Midregional Proatrial Natriuretic Peptide Predicts Survival in Exacerbations of COPD", Chest, (20110700), vol. 140, no. 1, pages 91 - 99, XP055452672
OPPOSITION- FONAROW et al., "An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry", Am Heart J, (20061214), vol. 153, no. 1, pages 74 - 81, XP005750603
OPPOSITION- GEMICI et al., "B-Type Natriuretic Peptide Levels in Patients with COPD and Normal Right Ventricular Function", Adv. Ther., (20080700), vol. 257, no. 7, pages 674 - 680, XP055033678
OPPOSITION- TUNG et al., "Amino-Terminal Pro-Brain Natriuretic Peptide for the diagnosis of Acute Heart Failure in Patients with Previous Obstructive Airway Disease", Annals of Emergency Medicine, (20060700), vol. 48, no. 1, pages 66 - 74, XP005505827
OPPOSITION- CELLI et al., "The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease", N Engl J Med, (20040304), vol. 350, no. 10, pages 1005 - 12, XP008140919
OPPOSITION- HURST et al., "Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease", Am J Respir Crit Care Med, (20061015), vol. 174, pages 867 - 874, XP055452670
OPPOSITION- LACOMA et al., "Biomarkers in the management of COPD", Eur Respir Rev, (20090529), vol. 18, no. 112, pages 96 - 104, XP055033728
OPPOSITION- STOLZ et al., "Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD", Chest, (20070400), vol. 131, no. 4, pages 1058 - 1067, XP002488254
OPPOSITION- STOLZ et al., "Plasma Pro-Adrenomedullin But Not Plasma Pro- Endothelin Predicts Survival in Exacerbations of COPD", Chest, (20080800), vol. 134, no. 2, pages 263 - 272, XP055033748
OPPOSITION- KOUTSOKERA et al., "Systemic Biomarkers in Exacerbations of COPD- the Evolving Clinical Challenge", Chest, (20120210), vol. 141, no. 2, pages 396 - 405, XP055452669

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents